← Back
$XERS All transactions

Xeris Biopharma Holdings, Inc.

F

$ Value

$79K

Shares

14,651

Price

$5

Filed

Aug 4

Insider

Name

McCulloch Kevin

Title

See Remarks

CIK

0002031695

Roles

Officer

Transaction Details

Transaction Date

2025-08-01

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,701,159

Footnotes

Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of August 1, 2025. | These shares include 7,225 shares that were purchased on June 30, 2025 due to participation by the reporting individual in the issuer's 2018 Employee Stock Purchase Plan. | The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Filing Info

Accession No.

0001867096-25-000123

Form Type

4

Issuer CIK

0001867096

McCulloch Kevin's History

Date Ticker Type Value
2026-01-31 XERS F $504K
2026-01-31 XERS F $223K
2026-01-31 XERS F $201K
2026-01-30 XERS A $0
2026-01-30 XERS A $0
2026-01-08 XERS $120K
2025-10-02 XERS F $6K
2025-09-11 XERS J $0
2025-08-01 XERS F $79K
2025-06-13 XERS $109K

Other Insiders at XERS (90d)

Insider Bought Sold Last
Shannon John Patrick Jr
See Remarks
2026-01-31
Hecht Beth
See Remarks
$224K 2026-04-01
Pieper Steven
See Remarks
2026-01-31
Brady James Aloysius $60K 2026-03-30
McCulloch Kevin
See Remarks
2026-01-31
Nguyen Anh Tu
See Remarks
2026-01-30